PROTEINHALTIGE ARZNEIMITTEL

History

What the Federal Institute of Intellectual Property published about this title, newest first.

1. Apr 29, 2019

   Maximum term reached

   Published in Swissreg on 29.04.2019

2. May 9, 2017

   Address changed

   Owner

   NPS Pharmaceuticals, Inc., 550 Hills Drive, 3rd Floor, Bedminster, NJ 07921, USA → SHIRE-NPS PHARMACEUTICALS, INC., 300 Shire Way, Lexington, MA02421, USA

   Published in Swissreg on 09.05.2017

3. May 9, 2017

   Agent entered

   Representative

   MICHELI & CIE SA, 122, Rue de Genève, Case postale 61, 1226 Thônex

   Published in Swissreg on 09.05.2017

4. Sep 23, 2008

   Transferred

   Owner

   NPS Allelix Corp., c/o Blake, Cassels & Graydon LLP, 199 Bay Street, Suite 2800, Commerce Court West, Toronto, ON M5L 1A9, Canada → NPS Pharmaceuticals, Inc., 550 Hills Drive, 3rd Floor, Bedminster, NJ 07921, USA

   Published in Swissreg on 23.09.2008

5. Sep 28, 2007

   Address changed

   Owner

   NPS Allelix Corp., 6850 Goreway Drive, Mississauga, Ontario, L4V 1V7, Canada → NPS Allelix Corp., c/o Blake, Cassels & Graydon LLP, 199 Bay Street, Suite 2800, Commerce Court West, Toronto, ON M5L 1A9, Canada

   Published in +pat+ No 18 in 2007

6. Aug 31, 2007

   Address changed

   Representative

   Patentanwälte Feldmann & Partner AG, Europastrasse 17, 8152 Glattbrugg → Schneider Feldmann AG, Patent- und Markenanwälte, Beethovenstrasse 49,, Postfach 2792, 8022 Zürich

   Published in +pat+ No 16 in 2007

7. Sep 30, 2004

   Agent entered

   Representative

   Patentanwälte Feldmann & Partner AG, Europastrasse 17, 8152 Glattbrugg

   Published in +pat+ No 18 in 2004

8. Aug 31, 2004

   Granted

   Published in +pat+ No 16 in 2004

Parties

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.